非体外循环冠状动脉旁路移植术在严重左心室功能不全患者中安全有效
本研究为单中心倾向性匹配回顾性分析,比较2002至2014年间1161例严重左心室功能不全患者接受非体外循环冠状动脉旁路移植术(OPCAB)与常规冠状动脉旁路移植术(ONCAB)的早期和长期结局。主要终点为长期全因死亡率。结果显示两组30天死亡率相当,OPCAB组住院时间更短、输血率更低,长期生存率无显著差异,尽管OPCAB组不完全血运重建更常见,但未增加远期死亡风险。
要点
- OPCAB与ONCAB在严重左心室功能不全患者中30天死亡率相当。
- OPCAB组住院时间更短且红细胞输注率更低。
- OPCAB组不完全血运重建更常见,但未增加远期死亡率。
核心结论
- 在严重左心室功能不全患者中,OPCAB安全有效,尽管不完全血运重建更常见,但未增加远期死亡风险。
研究设计与样本
- 回顾性单中心倾向性匹配分析,纳入2002至2014年间1161例连续接受孤立CABG的严重左心室功能不全患者,其中442例OPCAB、719例ONCAB,匹配后形成430对。
主要发现
- OPCAB组不完全血运重建发生率高于ONCAB组(35.3% vs 21.6%;P < 0.01)。
- 匹配组间30天死亡率总体为5%,两组比较无显著差异[OR 0.64(0.34-1.22);P = 0.18]。
- OPCAB组中位住院时间更短(11 vs 12天;P = 0.02),红细胞输注率更低[2.7(2.21-3.19) vs 4.4(3.56-5.24);P < 0.01]。
- OPCAB与ONCAB组1年、5年、10年估计调整生存率分别为86.0% vs 85.8%、69.1% vs 65.5%、59.9% vs 49.1%(P = 0.99),长期死亡风险相似[HR 0.94(0.66-1.32);P = 0.7]。
- 不完全血运重建与长期全因死亡风险增加呈弱关联[HR 1.33(0.99-1.77);P = 0.05]。
关键数值与推荐
- 严重左心室功能不全患者行OPCAB与ONCAB的30天死亡率OR 0.64(0.34-1.22),P = 0.18。
- OPCAB组不完全血运重建率35.3%,ONCAB组21.6%,P < 0.01。
- 长期死亡风险HR 0.94(0.66-1.32),P = 0.7。
临床怎么用
- 对于严重左心室功能不全患者,OPCAB可作为安全有效的血运重建选择。
- OPCAB虽可能增加不完全血运重建,但未观察到远期生存获益受损。
- 临床决策需综合评估血运重建完整性与手术风险。
局限性
- 回顾性单中心研究,存在选择偏倚可能。
- 倾向性匹配仅能控制已知混杂因素。
- 不完全血运重建与长期死亡的关联仅为弱显著性(P = 0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Severe left ventricular dysfunction (LVD) is associated with increased risk following coronary artery bypass grafting (CABG). Due to a dearth of reports on the choice of CABG technique in patients with LVD, this study aims to compare the outcomes of off-pump CABG (OPCAB) and conventional CABG (ONCAB) in such patients. METHODS: Retrospective single-centre propensity-matched analysis comparing early- and long-term outcomes of OPCAB and ONCAB in patients with severe LVD. Primary outcome was long-term all-cause mortality. RESULTS: Between 2002 and 2014, a total of 1161 consecutive patients with severe LVD underwent isolated CABG [442 patients underwent OPCAB and 719 ONCAB (430 matched pairs)]. Incomplete revascularization was observed more frequently among OPCAB than ONCAB patients (35.3% vs 21.6%; P < 0.01). The overall 30-day mortality was 5% and was comparable between the matched groups [OR 0.64 (0.34-1.22); P = 0.18]. OPCAB patients had shorter median hospital stay (11 vs 12 days; P = 0.02) and lower packed red blood cell transfusion rates [2.7 (2.21-3.19) vs 4.4 (3.56-5.24); P < 0.01]. Estimated adjusted survival was 86.0% vs 85.8%, 69.1% vs 65.5% and 59.9% vs 49.1% at 1, 5 and 10 years for OPCAB and ONCAB patients, respectively (P = 0.99). Long-term risk of mortality was similar between groups [hazard ratio (HR) 0.94 (0.66-1.32); P = 0.7]. Incomplete revascularization was weakly associated with increased risk of long-term all-cause mortality [HR 1.33 (0.99-1.77); P = 0.05]. CONCLUSIONS: OPCAB is safe and effective in patients with severe LVD. Although incomplete revascularization is more commonly observed in patients undergoing OPCAB, it is not associated with increased late mortality.
引用
- Marin-Cuartas M, Deo SV, Ramirez P, et al. Off-pump coronary artery bypass grafting is safe and effective in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 2022. PMID: 34392337. doi:10.1093/ejcts/ezab371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。